Showing results (361-370 of 1,022) with videos related to
Sort By:
Pageof 103
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1983
Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic diseaseA Girolami, V Pengo, G Cappellato, et al.Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1985
The use of laser-nephelometry in evaluating fibrinogenaemia in patients with hepatocarcinoma and cirrhosisA Girolami, S Antico, V Pengo, et al.Haematologia|January 1, 1987
A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiencyM G Capellato, A R Lazzaro, F Marafioti, et al.Blut|January 1, 1986
Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento)A Girolami, M G Cappellato, M A Vicarioto, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 24, 1998
Congenital deficiencies and abnormalities of prothrombinA Girolami, L Scarano, G Saggiorato, et al.Enfermedades Infecciosas Y Microbiologia Clinica|January 15, 1999
[Characterization of the rpoB gene mutations in clinical isolates of rifampicin-resistant Mycobacterium tuberculosis]N González, M J Torres, J C Palomares, et al.Thrombosis Research|November 1, 1985
Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exerciseA Estellés, G Tormo, J Aznar, et al.Thrombosis Research|May 1, 1992
Hemorheological alterations in mild essential hypertensionA Vayá, M Martínez, J Garcia, et al.Journal of Clinical Microbiology|September 2, 2000
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosisM J Torres, A Criado, J C Palomares, et al.Thrombosis Research|March 1, 1987
Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation productsV Vila, E Regañón, J Aznar, et al.Pageof 103